SPAGN Diagnosis Pathway Survey
The Global Sarcoma Diagnosis Pathway Survey is Now Closed!
Early diagnosis of sarcoma is crucial as it ensures that the tumor is discovered before the disease has spread extensively. This is why SPAGN conducted the Global Sarcoma Diagnosis Pathway Survey in 2024, focusing on the importance of early and accurate diagnosis. We are thrilled to share that more than 1,800 patients and caregivers participated in the survey, providing invaluable insights into their experiences.
We are currently analyzing the data collected from this survey to build upon the existing insights and address these knowledge gaps. The goal is to improve understanding and awareness of the sarcoma diagnosis pathway globally, ultimately benefiting the entire sarcoma community.
THANK YOU! 💙
A heartfelt thank you to the incredible 1,800+ patients and caregivers who took the time to participate and share their experiences. Your voices matter!
Stay tuned to this page for updates and the upcoming publication of the survey results!
Preliminary findings presented during CTOS
